Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0E3JL
|
||||
Former ID |
DIB011036
|
||||
Drug Name |
SL-25.1188
|
||||
Indication | Alzheimer disease [ICD9: 331; ICD10:G30] | Discontinued in Phase 1 | [547083] | ||
Company |
Sanofi-Synthelabo
|
||||
Target and Pathway | |||||
Target(s) | Amine oxidase [flavin-containing] B | Target Info | Inhibitor | [530356] | |
KEGG Pathway | Glycine, serine and threonine metabolism | ||||
Arginine and proline metabolism | |||||
Histidine metabolism | |||||
Tyrosine metabolism | |||||
Phenylalanine metabolism | |||||
Tryptophan metabolism | |||||
Drug metabolism - cytochrome P450 | |||||
Metabolic pathways | |||||
Serotonergic synapse | |||||
Dopaminergic synapse | |||||
Cocaine addiction | |||||
Amphetamine addiction | |||||
Alcoholism | |||||
Pathway Interaction Database | Alpha-synuclein signaling | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.